Localization of isoketal adducts in vivo using a single-chain antibody

The biochemistry of the isoprostane, neuroprostane, and isofuran Pathways of lipid peroxidation

Isoprostanes are prostaglandin-like compounds that are formed non-enzymatically by free radical-catalyzed peroxidation of arachidonic acid (C20:4omega6). Intermediates in the pathway of the formation of isoprostanes are labile prostaglandin H2-like bicyclic endoperoxides (H2-isoprostanes). H2-isoprostanes are reduced to form F-ring isoprostanes (F2-isoprostanes), but they also undergo chemical rearrangement in vivo to form E2- and D2-isoprostanes, isothromboxanes, and highly reactive acyclic y-ketoaldehdyes (isoketals). E2- and D2-isoprostanes also undergo dehydration in vivo to form cyclopentenone A2- and J2-isoprostanes. Docosahexaenoic acid (C22:6omega3) is highly enriched in neurons in the brain and is highly susceptible to oxidation. Free radical-catalyzed oxidation of docosahexaenoic acid results in the formation of isoprostane-like compounds (neuroprostanes). F4-, D4-, E4-, A4-, and J4-neuroprostanes and neuroketals have all been shown to be produced in vivo. In addition, we recently discovered a new pathway of lipid peroxidation that forms compounds with a substituted tetrahydrofuran ring (isofurans). Oxygen concentration differentially modulates the formation of isoprostanes and isofurans. As oxygen concentrations increase, the formation of isofurans is favored whereas the formation of isoprostanes becomes disfavored.

Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways

The cyclooxygenase (COX) pathway generates enantiomerically pure levuglandin (LG) E(2) by a rearrangement of the prostaglandin (PG) endoperoxide PGH(2). The isoprostane pathway generates racemic LGE(2) together with stereoisomers, designated collectively as isoLGE(2), through free radical-induced lipid oxidation. Within seconds, both LGs and isoLGs are rapidly sequestered by protein adduction. In theory, the diastereomeric purity of LGE(2)-protein adduct-derived lysyl lactams can reveal the relative contributions of the COX and isoprostane pathways to LGE(2) stereoisomer production in vivo. Notably, however, the detection of LGE(2)-protein adducts does not provide a basis for inferring their formation through the isoprostane pathway in vivo unless the COX pathway can be rigorously excluded. In contrast, LGE(2)structural isomers, designated collectively as iso[n]LGE(2)s, are produced exclusively through the isoprostane pathway. Immunoassays that selectively recognize iso[n]LGE(2)-protein adducts are the only tools available to unambiguously detect and quantify the production of isolevuglandins in vivo through free radical-induced oxidation of arachidonates.